Literature DB >> 2297466

Pelvic arteriovenous fistulas: therapeutic strategy in five cases.

C Laurian1, Y Leclef, F Gigou, I Alzaoubi, M C Riche, J P Melki, J M Cormier.   

Abstract

Pelvic arteriovenous fistulas are rare. They may be defined as arteriovenous communications developing in the pelvis from the internal iliac artery, the origin of its posterior trunk or branches of its anterior trunk. Congenital arteriovenous malformations, more common in women, and posttraumatic arteriovenous fistulas are the two main etiological forms. Diagnostic problems include appreciation of visceral extension in arteriovenous malformations and precise localization of fistulas especially when they affect the internal iliac artery itself. Therapy is aimed at complete closure of arteriovenous communications using interventional radiologic methods or surgery. Although indications are difficult to assess, complete, one-stage therapy is preferable due to surgical difficulties following failed or incomplete radiological or surgical attempts.

Entities:  

Mesh:

Year:  1990        PMID: 2297466     DOI: 10.1007/BF02042680

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  3 in total

1.  Uterine vascular lesions.

Authors:  Abhishek Vijayakumar; Amruthashree Srinivas; Babitha Moogali Chandrashekar; Avinash Vijayakumar
Journal:  Rev Obstet Gynecol       Date:  2013

Review 2.  Use of N-butyl cyanoacrylate in the successful transcatheter arterial embolization of an arteriovenous fistula caused by blunt pelvic fracture: A case report and review of literature.

Authors:  Hye Soo Cho; Yook Kim; Jisun Lee; Kyung Sik Yi; Chi-Hoon Choi
Journal:  Medicine (Baltimore)       Date:  2021-01-08       Impact factor: 1.817

3.  Holmium Laser Enucleation of the Prostate and Iatrogenic Arteriovenous Fistula Treated by Superselective Arterial Embolization.

Authors:  Anastasios D Asimakopoulos; Lorenzo Dutto; Paolo Preziosi; Enrico Spera; Francesco Micali; Andrea De Carolis; Beniamino Iorio
Journal:  Case Rep Urol       Date:  2016-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.